EHAB News and Press, Enhabit Inc. From 10/03/23

2023-10-03 17:47:00 ET Shares of Enhabit Inc. (NYSE: EHAB) were down more than 27% as of Tuesday's close, and the stock hit a 52-week low of $8.31. The healthcare company, in an Oct. 2 filing with the Securities and Exchange Commission (SEC), received a temporary waiver for a po...

2023-10-03 10:00:05 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...

2023-08-24 10:00:34 ET Gainers: CollPlant Biotechnologies ( CLGN ) +11% NeuBase Therapeutics ( NBSE ) +7% NeuroPace ( NPCE ) +7% Bionomics ( BNOX ) +6% Enhabit ( EHAB ) +16% Losers: NanoVibronix ( NAOV ) -15% ...

2023-08-23 17:00:56 ET More on Enhabit Enhabit: 40% Slump In Pre-Tax Earnings, Payer Headwinds Remain In Situ, Reiterate Hold Enhabit, Inc. ( EHAB ) Q2 2023 Earnings Call Transcript Enhabit: Difficult To Justify At 20x Earnings, Reiterate Hold Seeking Alp...

Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today announced that it has satisfied the conditions in its Tax Matters Agreement (“TMA”), dated June 30, 2022, with Encompass Health Corporation to conduct a review of strategic alternatives and has form...

2023-08-18 11:40:55 ET Summary Enhabit, Inc.'s shares have declined by 14% since the last publication due to ongoing headwinds in its business economics. The company is facing challenges with payer dynamics and a shift towards Medicare Advantage plans in its core markets. EHAB...

2023-08-12 00:04:10 ET Enhabit, Inc. (EHAB) Q2 2023 Earnings Conference Call August 10, 2023, 09:00 AM ET Company Participants Jordan Loyd - Mergers & Acquisitions Director, Corporate Development Barb Jacobsmeyer - President and Chief Executive Officer Crissy...

2023-08-09 16:56:54 ET Enhabit press release ( NYSE: EHAB ): Q2 Non-GAAP EPS of $0.04. Revenue of $262.3M (-2.1% Y/Y). Net loss of $74.1 million Adjusted EBITDA of $23.9 million Loss per diluted share of $1.49 For further details see: Enhabit Non-GAAP...

Revises Full-Year Guidance Announces Intent to Launch Strategic Alternatives Process Subject to Satisfaction of Conditions in Tax Matters Agreement Company to host a conference call tomorrow, August 10, 2023 at 10 AM EDT Enhabit, Inc. (NYSE: EHAB), a leading ho...

Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2023, on Aug. 9, 2023, and host a webcast and conference call on Aug. 10, 2023. Individuals who would like to participate in the conf...